Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Immundiagnostik
Bensheim, Hessen, Germanyimmundiagnostik.com ↗
- Ownership
- Private
- Employees
- ~75
- Development stage
- Commercial
01
Overview
Immundiagnostik AG develops and manufactures innovative in-vitro diagnostic kits—primarily immunoassays—and analytical solutions such as PCR, HPLC, LC-MS/MS kits. Their products are widely used in clinical laboratories worldwide to improve patient healthcare by enabling early diagnosis and disease risk prediction. The company maintains an active pipeline of proprietary developments.
- Therapeutic areas
- Other
- Modalities
- Immunoassay (ELISA, EIA)PCR-based diagnosticsHPLC-based diagnosticsLC-MS/MS-based diagnosticsAntibody/Antigen reagents
- Industry
- Molecular Diagnostics
02
Partnerships
Multiple cooperations with pharmaceutical industry partners and scientific organizations for product development
Beyond the preview
Go deeper on Immundiagnostik.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Immundiagnostik.